Drug intelligence / Profile preview

InnoPol-D

Development stage: Unknown
Lead developer: REGEN Biotech
Modality: Fragment-Derived Small Molecules → Multivalent & Scaffold-Based Small Molecules → Small Molecules
Administration: Surgical Implantation

Overview

InnoPol-D is a tissue-engineered scaffold developed by REGEN Biotech for dermal tissue regeneration and penile enlargement. Developed in collaboration with the Medical Science Center at the Korea Institute of Science and Technology (KIST) and the Biology Department of the Korea Advanced Institute of Science and Technology (KAIST), InnoPol-D serves as a structural matrix that supports the repair and replacement of damaged dermal tissues. It is categorized as a Tissue Engineering Manufactured Product (TEMP) and has received regulatory approval from the Korean Food and Drug Administration (KFDA).

Brand names: InnoPol-D
Other names: InnoPol D

Beyond the preview

Go deeper on InnoPol-D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoPol-D.

Explore the full profile